Article
Evolution of hematological parameters in HIV-1-infected patients with and without thalassemia carriages during highly active antiretroviral therapy.
HIV clinical trials - 1 Jan 2000
Pornprasert Sakorn, Sonboon Pakhaporn, Kiatwattanacharoen Suchart, Klinbuayaem Virat, Leenasirimakul Prattana, Promping Channat, Inta Prasit, Ajhan Siraporn, Leechanachai Pranee
Abstract excerpt
OBJECTIVES: To assess the effects of highly active antiretroviral therapy (HAART) on hematological parameters in HIV-1-infected patients with and without thalassemia carriages. METHODS: Prospective study was conducted in HIV-1-infected Thai patients receiving HAART. Their hematological parameters...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
